Peripheral Vascular Stents Market
Report ID: SQMIG35A3194
Report ID: SQMIG35A3194
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3194 |
Region:
Global |
Published Date: February, 2026
Pages:
186
|Tables:
67
|Figures:
65
Global Peripheral Vascular Stents Market size was valued at USD 4.8 Billion in 2024 and is poised to grow from USD 5.16 Billion in 2025 to USD 9.2 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).
The surging prevalence of cardiovascular diseases is slated to be the primary factor driving peripheral vascular stents market growth in the future. Increasing complications in cardiac cases due to diabetes and hypertension are also expected to promote the sales of peripheral vascular stents across the study period and beyond. Rapidly increasing senescent population on a global level also presents new opportunities for peripheral vascular stent companies in the long run. The growing popularity of minimally invasive surgeries and rising preference among patients for the same are also slated to open new avenues of opportunities for peripheral vascular stent providers to go forward. Adoption of poor lifestyles and consumption of a nutrition deficit diet are also factors that indirectly impact the peripheral vascular stents market outlook.
On the contrary, the risk of complications, competition from alternative treatments, and the shortage of trained vascular access nurses and clinicians, are all forecasted to slow down the global peripheral vascular stents industry in the long run.
How Image-Assisted Vascular Access is Revolutionizing Vascular Care?
Healthcare providers are rapidly adopting ultrasound-guided and image-assisted techniques to improve accuracy and safety during vascular access procedures. These technologies reduce insertion attempts, minimize vessel trauma, and lower infection risk, making them increasingly standard in hospitals and outpatient centers. Advancements in portable ultrasound systems and digital visualization tools enable real-time guidance, supporting better outcomes in complex or emergency cases. Training programs and clinical guidelines now emphasize image-guided placement as best practice. As clinicians prioritize precision, patient comfort, and reduced complications, adoption of imaging-assisted vascular access continues expanding globally, driving demand for compatible devices and enhancing procedural efficiency across care settings.
Market snapshot - 2026-2033
Global Market Size
USD 8.14 Billion
Largest Segment
Hospitals
Fastest Growth
Ambulatory Care Centers
Growth Rate
5.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Peripheral Vascular Stents Market is segmented by Product Type, Material Type, End User, Disease Type and region. Based on Product Type, the market is segmented into Bare Metal Stents, Drug-Eluting Stents and Bioresorbable Stents. Based on Material Type, the market is segmented into Stainless Steel, Cobalt-Chromium Alloy and Polymer-based. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialized Clinics. Based on Disease Type, the market is segmented into Peripheral Artery Disease, Coronary Artery Disease and Other Vascular Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The Short Peripheral Intravenous Catheters (Short PIVCs) segment is slated to account for a substantial peripheral vascular stents market share in the future. Extensive use of these products across hospitals, emergency departments, and outpatient settings is helping cement the dominance of this segment. Their simplicity, low cost, quick insertion, and versatility make the first choice of peripheral vascular stents in acute care, which further strengthens its high share on a global level.
Meanwhile, the demand for Peripherally Inserted Central Catheters (PICCs) is slated to increase at a rapid pace in the future as per these peripheral vascular stents for market analysis. PICCs offer a safer, less invasive alternative to traditional central venous access, which is why their adoption is slated to rise as preference for minimally invasive surgeries also rises.
Hospitals are estimated to spearhead global peripheral vascular stents market revenue generation across the study period. Administration of long-term intravenous therapies and high surgical procedure volumes in hospitals are expected to help this segment hold sway over others. Their strong clinical infrastructure, skilled healthcare personnel, and adherence to strict safety protocols further reinforce hospitals as the primary and most influential end-use segment.
On the other hand, the demand for peripheral vascular stents in ambulatory care centers is forecasted to rise at an impressive pace across the forecast period and beyond. High interest in outpatient procedures and adoption of home-transition therapies is expected to expand the business scope of peripheral vascular stents providers focusing on this end of use.
To get detailed segments analysis, Request a Free Sample Report
High vascular procedural volumes and early adoption of advanced peripheral vascular stents are helping this region hold sway over others. Surging incidence of chronic diseases such as cancer, kidney disorders, and cardiovascular conditions ensures consistent demand for peripheral vascular stents. Strong reimbursement frameworks, continuous product innovation, and widespread use of image-guided vascular access are also cementing North America’s dominance in terms of peripheral vascular stents demand on a global level.
Need for long-term intravenous therapy for indications such as cancer, renal failure, and autoimmune disorders is primarily shaping the adoption of peripheral vascular stents in the United States. Continuous technological innovation, favorable reimbursement policies, and presence of major manufacturers are also helping cement the dominance of this country in North America. Strong adherence to clinical safety mandates and advanced healthcare infrastructure reinforces the country’s dominant stance for the future.
High emphasis on infection prevention within healthcare systems and surging surgical procedure volumes are governing sales of peripheral vascular stents in Canada. Rise in patient preference for outpatient treatment, adoption of home infusion therapies, and strong nursing specialization in vascular access are helping drive revenue generation in this country. Preference for ultrasound-guided and image-assisted insertion techniques is high in Canadian hospitals.
Expansion of healthcare infrastructure and rising spending on advanced healthcare solutions are estimated to make Asia Pacific the most rewarding region for peripheral vascular stents suppliers. Growing demand for cancer treatments, dialysis procedures, and a rise in number of critical care admissions are also expected to boost the sales of peripheral vascular stents. Expanding medical tourism activity and growing preference for minimally invasive procedures are also estimated to generate new business scope for peripheral vascular stents companies in the long run.
Presence of a massive geriatric population and significant demand for long-term intravenous therapies make Japan a key market for peripheral vascular stents. The country’s emphasis on infection prevention, precision medicine, and standardized clinical protocols also create a lucrative setting for peripheral vascular stents adoption. Continuous technological innovation and stringent quality expectations are boosting the sales of advanced peripheral vascular stents.
Quick adoption of advanced healthcare technologies and rising chronic disease burden are driving up the demand for peripheral vascular stents in South Korea. Government support for medical innovation, launch of new healthcare modernization initiatives, and rising medical tourism are ensuring consistent sales of peripheral vascular stents in the country. Presence of a skilled clinical workforce and strong hospital protocols are also ensuring sustained market development.
Presence of well-developed hospital networks and advanced clinical standards make Europe a steadily expanding market for peripheral vascular stents vendors. Rise in adoption of long-term intravenous therapies and expanding geriatric population are also slated to boost the adoption of peripheral vascular stents going forward. While growth is slower than Asia Pacific, Europe remains a significant, innovation-driven market with consistent procedural demand across major healthcare systems.
Strict infection control protocols and adoption of advanced imaging technologies are expected to augment the demand for peripheral vascular stents over the coming years. Rising number of cancer treatments and dialysis procedures being performed in Germany are also creating new business scope for peripheral vascular stents providers. Strong regulatory frameworks, robust R&D presence, and highly developed healthcare infrastructure make this country a developed market for peripheral vascular stents companies going forward.
Strong clinical governance and emphasis on minimizing catheter-related complications are shaping the peripheral vascular stents industry in the United Kingdom. The National Health Service (NHS) maintains standardized vascular access pathways, which creates high demand for antimicrobial-coated devices. Investment in workforce training and rising integration of digital and image-assisted technologies further enhance the country’s adoption of vascular access solutions.
High adoption of evidence-based vascular access protocols in hospitals is governing the adoption of peripheral vascular stents in France. Rising demand for ultrasound-guided insertion, standardized training, and multidisciplinary vascular access teams makes this country a highly advanced market in the European region. The country’s commitment to patient safety and clinical quality improvement drives continual demand for novel peripheral vascular stents through 2032 and beyond.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Use of Home Healthcare and Outpatient Infusion Therapy
Rising Preference for Minimally Invasive Procedures and Improved Patient Safety Standards
Shortage of Skilled Professionals for Vascular Access Procedures
Regulatory Challenges and Stringent Compliance Requirements
Request Free Customization of this report to help us to meet your business objectives.
Peripheral vascular stent manufacturers should focus on making their products more affordable to enhance the accessibility to vascular procedures. Addressing the risks of complications and failures will also be crucial in determining the peripheral vascular stents industry growth potential going forward. Peripheral vascular stents providers should also focus on gaining new approvals for advanced peripheral vascular stents designed for minimally invasive procedures.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising prevalence of chronic diseases and growing emphasis on safe, reliable intravenous therapy are anticipated to drive the demand for peripheral vascular stents going forward. Contrastingly, risks of catheter-related infections and procedural complications are slated to slow down the adoption of peripheral vascular stents through 2032. North America is slated to spearhead the demand for peripheral vascular stents owing to high emphasis on advanced clinical standards and presence of a developed healthcare infrastructure. Development of antimicrobial-coated devices and integration with image-guided insertion technologies are anticipated to be key trends driving the peripheral vascular stents sector in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 4.8 Billion |
| Market size value in 2033 | USD 9.2 Billion |
| Growth Rate | 7.5% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Peripheral Vascular Stents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peripheral Vascular Stents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peripheral Vascular Stents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peripheral Vascular Stents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Peripheral Vascular Stents Market size was valued at USD 8.14 Billion in 2025 and is poised to grow from USD 8.58 Billion in 2026 to USD 12.77 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2025-2032)
Peripheral vascular stent manufacturers should focus on making their products more affordable to enhance the accessibility to vascular procedures. Addressing the risks of complications and failures will also be crucial in determining the peripheral vascular stents industry growth potential going forward. Peripheral vascular stents providers should also focus on gaining new approvals for advanced peripheral vascular stents designed for minimally invasive procedures. 'Teleflex Medical', 'BD', 'Smith’s Medical (ICU Medical Inc.)', 'Terumo Medical Corporation', 'Access Vascular Inc.', 'B. Braun', 'Medtronic', 'Medical Components Inc.', 'AngioDynamics', 'Cook Medical'
The world has witnessed a robust increase in popularity of home-based and outpatient care, which is slated to drive up the sales of peripheral vascular stents. Peripheral vascular stents play a crucial role in drug delivery for patients receiving antibiotics, immunotherapy, nutrition, or chronic disease treatments. Hence, growing emphasis on patient-centered care around the world is forecasted to favor the global peripheral vascular stent market outlook in the future.
Growth of Home Infusion Therapy and Long-Term Ambulatory Care Devices: Peripheral vascular stent suppliers are developing new offerings that can be used for home infusion therapy and outside hospital environments. Devices with improved durability, lower infection risk, and user-friendly maintenance features are gaining traction. Increasing inclination towards home-based care to reduce costs and hospital burden, makes this a prominent peripheral vascular stent market trends for the future.
Why is Demand for Peripheral Vascular Stents Highest in North America?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
